Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
58155 Results Found
Mount Sinai joins effort to develop COVID-19 hyperimmune globulin product candidate
The Mount Sinai Health System will partner with Emergent BioSolutions and ImmunoTek Bio Centers on the development and evaluation of a COVID-19 hyperimmune globulin product, it was announced.
FBI PIN TLP White: Criminals and Nation-State Cyber Actors Conducting Widespread Pursuit
Criminal and nation-state cyber actors since February 2020 have been increasingly targeting US pharmaceutical, medical, and biological research facilities to acquire or manipulate sensitive information, to include COVID-19 vaccine and treatment research amid the evolving global pandemic.
Coronavirus Update: Congress Reaches Deal on $8.3 Billion Coronavirus Spending Package
Congressional leaders today reached a deal on an $8.3 billion spending package to combat the novel coronavirus (C
Administration officials discuss remdesivir distribution, reopening and testing at Senate HELP hearing
The federal government continues to learn lessons about distributing COVID-19 therapeutics, such as remdesivir, Food and Drug Administration Commissioner Stephen Hahn, M.D., said at a Senate Health, Education, Labor and Pensions Committee hearing.
Former AHA Chair Woods discusses COVID-19 on Face the Nation
Atrium Health President and CEO Eugene Woods spoke on CBS’s Face the Nation about the lack of reagents for COVID-19 testing, racial disparities during the pandemic and treating thousands of COVID-19 patients in their homes.
Administration announces initiative to speed development, distribution of COVID-19 vaccines, therapeutics and diagnostics
The Trump administration introduced Operation Warp Speed, a $10 billion public-private partnership intended to accelerate development, manufacturing and distribution of COVID-19 vaccines, therapeutics and diagnostics by January 2021.
HHS, Defense Department invest in manufacturing demonstration to produce 100 million COVID-19 investigational vaccine doses
The Department of Health and Human Services announced that it will partner with the Department of Defense to fund the advanced development — including clinical trials and large-scale manufacturing — of a COVID-19 investigational vaccine from Sanofi and GlaxoSmithKline.
NASEM releases draft framework for allocating a COVID-19 vaccine, seeks public comment
The National Academies of Sciences, Engineering, and Medicine today released for public comment a discussion draft of a preliminary framework to assist policymakers in planning for equitable allocation of a vaccine against COVID-19.
AHA Comments on NASEM’s Discussion Draft of the Preliminary Framework for Equitable Allocation of COVID-19 Vaccine
AHA comments on the National Academies of Sciences, Engineering and Medicine’s Discussion Draft of the Preliminary Framework for Equitable Allocation of COVID-19 Vaccine.